Our team
Peter Bauer, M.D., Ph.D.CEO, Executive Head, Responsible Person for the Tissue Establishment, Clinical Research Manager, Pharmacovigilance Manager, RnD
Peter Bauer, M.D., Ph.D.CEO, Executive Head, Responsible Person for the Tissue Establishment, Clinical Research Manager, Pharmacovigilance Manager, RnD
Peter completed his medical and postgraduate (Molecular Genetics, Biology and Virology program) studies at the 3rd and 2nd Medical Faculty of Charles University in Prague, respectively. During his scientific carrier, he has worked at RIKEN Brain Science Institute in Japan, National Institute of Health (National Cancer Institute), and Mayo Clinic in the USA.
Peter became the CEO of Bioinova in 2016.
Ivana Drahorádová, MSc. Coordinator of Production Activities, Qualified Person
Ivana Drahorádová, MSc. Coordinator of Production Activities, Qualified Person
Ivana completed her studies at the Faculty of Chemical Technology of Pardubice University. For more than 25 years, she has been working in quality control of immunological products manufactured by a Czech pharmaceutical company where she became a Qualified person in 1998.
Ivana is now exploiting her extensive experience in the set up and maintenance of rules for ATMPs production under GMP regimen as well as for harvesting and processing of tissues and cells in the Tissue Establishment regimen. She ensures and guarantees the quality and safety of our products in accordance to the legislation and tightening requirements of the regulatory authorities.
Kateřina Růžičková, Ph.D.Clinical Research Associate
Kateřina Růžičková, Ph.D.Clinical Research Associate
Katerina graduated from the Faculty of Science of Charles University in Prague (Biochemistry) and obtained her postdoctoral degree at the 1st Medical Faculty of Charles University in Neuroscience. As a visiting fellow, she had positions in Seattle, United States; Budapest, Hungary; and Cologne, Germany. After her studies, she worked at the Institute of Experimental Medicine of the Czech Academy of Sciences for 14 years. Since 2011, Katerina has been the Head of the Quality Control Department, since 2018, Qualified Person in Bioinova. In 2019, she also became Responsible Person for the Tissue Establishment. She currently works as a Clinical Research Associate.
Production Department
Jana Gujski, MSc.Head of the Production Department
Jana Gujski, MSc.Head of the Production Department
Jana graduated at the University of Chemistry and Technology in Prague (Biotechnology of Pharmaceuticals). Within her studies she had been focusing on targeted therapy of cancer and specifically, testing of novel photosensitive molecules in cell cultures. During her last year at the university, she has started to work in Bioinova and subsequently joined the team fulltime in October 2018. Her main RnD focus is cryopreservation of stem cells.
Quality Control Department
Barbora Codlová, MSc.Head of the Quality Control Department
Barbora Codlová, MSc.Head of the Quality Control Department
Barbora graduated from the Czech University of Life Sciences Prague (Reproductive Biotechnologies). After completion of her studies, she worked in the Quality Control Department where she was responsible for quality control procedures of stem-cell-based products in veterinary medicine.
She joined Bioinova Quality Control Department in November 2021. Her main focus is ATMP (advanced therapy medicinal products) related quality control procedures (qPCR, flow cytometry) and custom quality control.
Consultants
Tomáš Groh, MSc., Ph.D.Consultant
Tomáš Groh, MSc., Ph.D.Consultant
Tomas graduated at the Faculty of Science of Charles University in Prague (Biochemistry). During his studies, he visited Universitat de València in Spain. He worked at the 2nd Medical Faculty of Charles University in the field of anticancer therapy, where he also obtained his postdoctoral degree on mechanism of anticancer therapies in neuroblastomas.
In Bioinova, Tomas has been involved in numerous projects including development of novel product for clinical testing. He has also been responsible for introduction and validation of new methods for QC of the medicinal products.
Tomas has been with Bioinova since 2015 and he is a co-author of several company patents.